Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2003
06/26/2003US20030119869 1-(Piperidin-4-yl)benzimidazole or -triazole derivatives; agonists and antagonist for beta-chemokine (chemotactic cytokines) receptors; viricides; HIV; antiarthritic agents; atherosclerosis, psoriasis, antiallergens; multiple sclerosis
06/26/2003US20030119854 Compounds and methods for modulating CXCR3 function
06/26/2003US20030119853 Thiocarboxamide derivatives
06/26/2003US20030119847 Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1
06/26/2003US20030119838 Water-soluble phenylpyridazine compounds and compositions containing the same
06/26/2003US20030119836 Cyclooxygenase inhibitors
06/26/2003US20030119835 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119829 4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions
06/26/2003US20030119827 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases
06/26/2003US20030119825 Highly concentrated stable meloxicam solutions for needleless injection
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119800 Administering an ANGELS (Activators of Non-Genotropic Estrogen-like Signaling compound"ANGELS") compound to maintain or increase bone mass, bone density and/or bone strength.
06/26/2003US20030119797 Methods for selective immunomodulation
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119786 Combinations for the treatment of immunoinflammatory disorders
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119727 FVIIa antagonists
06/26/2003US20030119149 Fusion protein capable of forming a trimer; nonimmunogenic; modulates signaling of tumor necrosis family receptors
06/26/2003US20030119148 Amino-terminally truncated rantes as chemokine antagonists
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119072 Methods for modulating signal transduction mediated by TGF-beta related proteins
06/26/2003US20030118672 Administering a stabilized rice bran derivative and a fortification agent; treating bone disorders
06/26/2003US20030118600 Transfer compounds, production and use thereof
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118575 Administering a pyrazole compound containing urea or thiourea groups, twice daily to a patient in need of treatment of a cytokine mediated disease
06/26/2003US20030118559 Contacting the bodily fluid of a patient with renal tubule cells outside of the kidney for treating systemic inflammatory response syndrome (SIRS)
06/26/2003US20030118536 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003US20030118528 Topical delivery of codrugs
06/26/2003US20030118508 Treatment of osteomyelitis with radiopharmaceuticals
06/26/2003US20030118507 Methods of using 46828, a human acyl-CoA synthetase
06/26/2003CA2473938A1 Human adam-10 inhibitors
06/26/2003CA2473877A1 Substituted beta-aminoalcohols as pharmaceutical preparations
06/26/2003CA2471589A1 Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
06/26/2003CA2471500A1 Substituted 1,5-diaminopentan-3-ol compounds
06/26/2003CA2470763A1 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
06/26/2003CA2470723A1 3,4-dihydro-1h-isoquinolin-2-yl-derivatives
06/26/2003CA2470236A1 Lactams as tachykinin antagonists
06/26/2003CA2470060A1 Improvements in pharmaceutical compositions
06/26/2003CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003CA2469976A1 Improvements in pharmaceutical compositions
06/26/2003CA2469944A1 Medicaments comprising n, n'-disubstituted piperazine compounds and their use
06/26/2003CA2469200A1 Analgesic delivery systems and methods of use
06/26/2003CA2469048A1 Quinolinones as prostaglandin receptor ligands
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/26/2003CA2465888A1 Topical compositions and methods for treatment of adverse effects of ionizing radiation
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/25/2003EP1321169A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament
06/25/2003EP1321123A1 Use of an extract of Baptisia tinctoria in a cosmetic composition
06/25/2003EP1320614A2 Novel proteases
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320584A2 Transferases
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320532A1 Tetrapyrroles
06/25/2003EP1320526A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP1320386A1 A novel cationic lipopolymer as biocompatible gene delivery agent
06/25/2003EP1320369A1 A method of analgesia
06/25/2003EP1320365A1 Substituted azole derivatives as inhibitors of corticotropin releasing factor
06/25/2003EP1224178B1 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
06/25/2003EP1178981B1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
06/25/2003EP1135417B1 Polysaccharide chiral esters, one of the methods for preparing them and their uses for obtaining optically enriched acids or chiral chromatography
06/25/2003EP0874824B1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0726074B1 Method for obtaining apolar and polar extracts of curcuma and applications thereof
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/25/2003CN1426461A Method of producing membrane vesicles
06/25/2003CN1426419A Pharmaceutical compositions containing oligosaccharides and preparation thereof
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426411A 3-(diarylmethylene)-8-azabicyclo [3,2,1] octane derivatives
06/25/2003CN1426409A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426396A Substituted benzoic acid amides and use for inhibition of angiogenesis thereof
06/25/2003CN1426395A Inhibitors of dipeptidyl peptidase IV
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426392A Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
06/25/2003CN1426304A Chemical Modification of mammalian urine and blood
06/25/2003CN1426303A Thiazole, imidazole and oxazole compounds and treatments of disorder associated with protein aging
06/25/2003CN1425457A Granular preparation for dysmenorrhea
06/25/2003CN1425454A Swelling pain relieving medicine and its preparing process
06/25/2003CN1425451A Baikangtie plaster and its preparing method
06/25/2003CN1425446A Pill for activating collateral flow and removing spur
06/25/2003CN1425436A Traditional Chinese medicine preparation for curing gynecopathy
06/25/2003CN1425431A Bone marrow recovery medicine
06/25/2003CN1425410A Traditional Chinese medicine preparation for curing rheumatism
06/25/2003CN1425399A Traditional Chinese medicine composition for curing rheumatism
06/25/2003CN1425395A Bolus for eliminating arthralgia and activating energy flow in channels and collaterals and its preparing method
06/25/2003CN1425394A Bolus for eliminating arthralgia and activating energy flow in channels and collaterals and its preparing method
06/25/2003CN1112359C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF)
06/25/2003CN1112191C Medicine for treating rheumatic arthritis and hyperosteogeny and its preparing process
06/25/2003CN1112180C Pharmaceutical composition containing drug/beta-cyclodextrin complex in combinection with acid-base couple
06/24/2003US6583321 4′-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor
06/24/2003US6583309 Ureas and compositions thereof for treating cancer, inflammation, or a viral infection
1 ... 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 ... 1272